(Q50990951)

English

Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple doses.

scientific article published in January 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple doses. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

N R Srinivas

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

R S Weiner

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

G Warner

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

W C Shyu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

T Davidson

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

C G Fadrowski

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

L K Tay

7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

J S Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

D S Greene

9

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

R H Barbhaiya

10

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

language of work or name

0 references

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

Journal of Pharmaceutical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

85

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

1-4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

CTLA-4 is a second receptor for the B cell activation antigen B7

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of murine lupus with CTLA4Ig

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-clinical toxicity of Il-4: A model for studying protein therapeutics

1 reference

https://api.crossref.org/works/10.1021%2FJS950347D

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1021/JS950347D

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/8926572

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50990951&oldid=2144482240"